(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
A cognitive behavioral and structural HIV prevention intervention for young Ugandan women engaging in high risk sexual behavior |
Rachel King, PhD, MPH |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention |
|
|
A New Field Assay to Diagnose and Monitor Schistosomiasis |
|
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C |
Anne Luetkemeyer, MD |
Sexually Transmitted Infections (STIs) |
|
|
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) |
Anne Luetkemeyer, MD |
Sexually Transmitted Infections (STIs) |
|
|
A Phase I Safety Trial of the Diaphragm in Zimbabwe |
|
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning |
|
|
A smartphone-based point-of-care test for detection of Chlamydia trachomatis |
Julius Schachter, PhD |
Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
Acceptability of Barrier Methods for Disease Prevention |
|
Sexually Transmitted Infections (STIs) |
|
|
Acceptability of Diaphragm Use to Prevent STDs/HIV |
|
Sexually Transmitted Infections (STIs), Women's Health |
|
|
Acute Hepatitis C Infection in Young Injectors |
Kimberly Page, PhD, MPH |
Sexually Transmitted Infections (STIs) |
|
|
AIDS Education and Training Center, National Clinician Consultation Center |
Ronald Goldschmidt, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education |
|
|
AMC-103: A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive Individuals |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs) |
|
|
An Intervention for Male STD Patients in India / HIV Related |
Christina (Krysia) Lindan, MD, MSc |
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|
APTIMA HPV Clinical Study on Anal Specimens from Men Who Have Sex with Men (MSM) |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs) |
|
|
Bay Area Hepatitis C Cooperative Research Center |
Mike McCune, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs) |
|
|
Cambodia Integrated HIV and Drug Prevention Implementation |
Ellen Stein, MPH |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence |
|
|
Chlamydia and Gonococcal Infection: Immunobiology in the Female Reproductive Tract |
Craig Cohen, MD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health |
|
|
Chlamydial sexually transmitted diseases and trachoma |
Deborah Dean, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Congenital Syphilis Elimination Cost-Effectiveness Analysis |
James Kahn, MD, MPH |
Sexually Transmitted Infections (STIs), Health Economics and Effectiveness |
|
|
Content from UCSF Physicians for SexReally.com |
J. Joseph Speidel, MD, MPH |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning, Adolescent Health, Patient and Peer Education |
|
|
Dynamic Modeling of the Hepatitis C Epidemic in Injection Drug Users |
Judith Hahn, PhD, MD |
Sexually Transmitted Infections (STIs), Epidemiology and Surveillance |
|
|
Economic Opportunity for Zimbabwean Adolescent Orphans |
Philip Darney, MD, MS |
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|
End HepC SF research to inform elimination |
Meghan Morris, PhD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs) |
|
|
Evaluation of Abbott RealTime CT/NG for the Detection of C. trachomatis & N. gonorrhoeae from the Pharynx, Rectum & Urethra of MSM |
Julius Schachter, PhD |
Sexually Transmitted Infections (STIs) |
|
|
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men |
Anne Luetkemeyer, MD |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Expedited Partner Therapy and the HIV Prevention Cascade Among MSM in Peru |
Catherine Oldenburg, ScD, MPH |
Sexually Transmitted Infections (STIs) |
|
|
FACES Patient Care fund for research at Kenya |
Craig Cohen, MD, MPH |
HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Diet, Exercise, and Obesity, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Stigma and Discrimination, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis |
Grace Turyasingura, MSc |
Sexually Transmitted Infections (STIs) |
|
|
HBV/HIV Co-Infection Research Network |
Mandana Khalili, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|
HCV Infection and Treatment in Parolees: Feasibility Study |
Kimberly Page, PhD, MPH |
Sexually Transmitted Infections (STIs) |
|
|
HCV Prevention and Care Education |
Kimberly Page, PhD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Patient and Peer Education |
|
|
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant) |
|
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|
Hepatitis C: Studies of Immunity and Pathogenesis |
Kimberly Page, PhD, MPH |
Sexually Transmitted Infections (STIs) |
|
|
High throughput proteomics to dissect Chlamydia-host cell interactions |
Joanne Engel, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Genetics, Risk Reduction and Prevention |
|
|
HIV Risk Reduction Through HSV-2 Prevention with N-9 |
|
Sexually Transmitted Infections (STIs) |
|
|
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health |
|
|
HSV-2 Avidity Testing for Intervention for Male Sexually-Transmitted Disease (STD) Patients in India |
Christina (Krysia) Lindan, MD, MSc |
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|
Identifying Community Factors Impacting STIs among Youth in California |
Claire Brindis, DrPH |
Sexually Transmitted Infections (STIs), Adolescent Health |
|
|
Identifying Opportunities to Increase Syphilis Partner Services Uptake and Improve Outcome Measures, San Francisco - Phase II |
Kim Koester, PhD |
Sexually Transmitted Infections (STIs), Engagement in Care |
|
|
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants |
Marion Peters, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health |
|
|
Implementation science and reproductive health on sub-Saharan Africa |
Joelle Brown, PhD |
HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health, Labor and Delivery, Family Planning |
|
|
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy |
Michael J. Reid, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening |
|
|
Improving Uses of New and Existing Technologies to Reduce Non-viral STIs in Developing Countries |
|
Sexually Transmitted Infections (STIs) |
|
|
In Vivo Drug Interaction Study |
|
Sexually Transmitted Infections (STIs), Family Planning |
|
|
Incidence, Prevalence and Risk Factors for Sexually Transmitted Infections in Fiji |
Deborah Dean, MD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
Informing hepatitis C virus elimination strategies with epidemiological data from highest need populations |
Meghan Morris, PhD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Epidemiology and Surveillance |
|
|
Insulin Resistance in HCV Infection |
Mandana Khalili, MD |
Sexually Transmitted Infections (STIs) |
|
|
Intervention to Decrease Risk for STDs and Unintended Pregnancies in Active Duty Military Women |
|
Sexually Transmitted Infections (STIs), Women's Health, Family Planning |
|
|
Investigation of the Natural History of Human Papillomavirus (HPV) DNA and Cervical Neoplasia in a Cohort of Sex Workers in Kenya |
Craig Cohen, MD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health |
|
|
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis |
Mandana Khalili, MD |
Sexually Transmitted Infections (STIs) |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Microbicide Pregnancy Registry-Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health |
|
|
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 |
Henry Chambers, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance |
|
|
Mycoplasma Genitalium in the Female Genital Tract |
Craig Cohen, MD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health |
|
|
Nanotextured Condoms: Surface Engineering for Better Safe Sex |
|
Sexually Transmitted Infections (STIs) |
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women |
Joel Palefsky, MD |
HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Novel approaches to identify host genes required for Chlamydia pathogenesis |
Joanne Engel, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
Outreach-based STI and HIV testing for street youth in San Francisco |
Colette L. Auerswald, MD, MS |
Sexually Transmitted Infections (STIs), HIV/AIDS, Adolescent Health, Stigma and Discrimination, Risk Reduction and Prevention |
|
|
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 |
Mandana Khalili, MD |
Sexually Transmitted Infections (STIs) |
|
|
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa |
Craig Cohen, MD, MPH |
HIV/AIDS, Sexually Transmitted Infections (STIs), Women's Health |
|
|
Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Women's Health |
|
|
Preclinical Development of MucoCept |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Women's Health |
|
|
Prevalence of and Behaviors Associated with Chlamydia Trachomatis Sexually Transmitted Infections among Females in Suva, Fiji |
Ginny Svigals, MS |
Sexually Transmitted Infections (STIs) |
|
|
Prevalence, incidence and risk factors for genital and rectal C. trachomatis and N. gonorrhoeae infections and antibiotic resistance in Fiji |
Deborah Dean, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
Providers' Perceptions of the Diaphragm in Southern Africa and the United States |
Cynthia Harper, PhD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Training International Scholars and Clinicians, UCSF Professional Education |
|
|
Purine Metabolism in Trichomonas Vaginalis |
|
Infectious Disease, Sexually Transmitted Infections (STIs) |
|
|
Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission |
Ariane Van der Straten, PhD, MPH |
Sexually Transmitted Infections (STIs), HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Reducing Health Disparities in Unintended Pregnancies Among Hispanic Adolescents Using a Patient-Centered Computer-Based Clinic Intervention |
|
Sexually Transmitted Infections (STIs), Family Planning, Adolescent Health |
|
|
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C |
Anne Luetkemeyer, MD |
Sexually Transmitted Infections (STIs) |
|
|
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C |
Anne Luetkemeyer, MD |
Sexually Transmitted Infections (STIs) |
|
|
Retrovirus Epidemiology Donor Study-II (REDS-II) Central Laboratory |
Mark Seielstad, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Transfusion Medicine, Health Systems Strengthening |
|
|
Role of HIV in acceleration of HPV malignancy |
Sharof Tugizov, PhD |
HIV/AIDS, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
San Francisco STDs CRC |
|
Sexually Transmitted Infections (STIs), Adolescent Health |
|
|
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health |
|
|
Sexually Transmitted Disease Prevention Projects: Implementation |
George Rutherford, MD |
Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
Sexually Transmitted Infections Clinical Trials Group (STICTG) |
Linda Giudice, MD, PhD, MSc |
Sexually Transmitted Infections (STIs) |
|
|
State Sexually Transmitted Disease Collaborative Program |
George Rutherford, MD |
Sexually Transmitted Infections (STIs) |
|
|
State Sexually Transmitted Disease Collaborative Program |
George Rutherford, MD |
Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
STD and Viral Hepatitis Prevention and Control |
George Rutherford, MD |
Infectious Disease, Sexually Transmitted Infections (STIs) |
|
|
STD Prevention Training Center |
George Rutherford, MD |
Sexually Transmitted Infections (STIs), Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education |
|
|
STD Risks and Latino Adolescents' Sexual Networks |
|
Sexually Transmitted Infections (STIs), Adolescent Health |
|
|
STI Screening as a Combined HIV Prevention Platform for MSM in Peru |
James Dilley, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Engagement in Care |
|
|
Support for Male Circumcision Evaluatation Meeting |
George Rutherford, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Risk Reduction and Prevention |
|
|
Thai Red Cross S&S, HN177 |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Thai Red Cross S&S, HPV TA008 |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
The No One Waits (NOW) Study: Acceptability, feasibility, and effectiveness of a community based on-site point-of-diagnosis HCV treatment study |
Meghan Morris, PhD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), Pharmacology and Drug Treatment, Epidemiology and Surveillance |
|
|
Treatment of Acute Hepatitis C Virus in HIV Co-Infection |
|
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads |
Meghan Morris, PhD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
UZ-UCSF Clinical Trials Unit |
Zvavahera Chirenje, MD, FRCOG |
Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health |
|
|
Vulnerable youth, homelessness, and risk behaviors |
Colette L. Auerswald, MD, MS |
HIV/AIDS, Sexually Transmitted Infections (STIs), Access or Barriers to Care, Stigma and Discrimination |
|
|
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) |
|
Sexually Transmitted Infections (STIs), HIV/AIDS |
|
|